Home Blog Page 141

The Art and Science of Compounding Medicine

0
The Art and Science of Compounding Medicine

How Swan Lake Pharmacy is transforming pain care through compounding medicine
—by Toni-Marie Ippolito

“We’re trying to get people off of pain pill medication,” is not a statement you would normally associate with a pharmacy. Most pharmacies are in the business of distributing pills and the medications you need to help with whatever ails you. But in the case of Swan Lake Pharmacy, located in Markham, Ont., this statement is their mission.

Established in 2017, Swan Lake Pharmacy was started by Lina Youssef, manager and owner, who was inspired to take her knowledge of pharmaceuticals one step further by focusing on the business of custom, compounding medicine.

A graduate of Ain Shams University in her home country of Cairo, Youssef moved to Canada in 2010 and got her pharmaceutical license in 2012. After working mostly in the retail area of the pharma industry, her interest in compounding medicine took hold after working for an organization that licensed pharmacists to practice in this area.

Her business, Swan Lake Pharmacy, which has been awarded one of “The Top 3 pharmacies” in the area (according to ThreeBestRated.ca) would be built on this type of treatment.

What is compounding medicine?

In a world where bespoke and customization is becoming a big trend in all areas including cosmetics, fashion, and skin care, medical prescriptions are following suit. According to the PCCA (Professional Compounding Centers of America) compounding medication “is the art and science of preparing customized medications for patients.”

This is something that Swan Lake Pharmacy is spearheading in the form of topical compounding medicinal creams to manage pain. Not only is it customized, but it can also target a specific area of pain directly where sometimes a pill cannot.

“People have been very responsive to compound medicine,” Youssef says. “But this is not a new concept. These compounds have been around for years. It’s actually huge in the US, but in Canada dealing with pain treatment alternatives have been slower in terms of getting the word out. It’s just not something that is advertised or known to people.”

From Pills to Creams

When it comes to pain management, Youssef is always learning when it comes to advancements in patient care. Which is why her pharmacy is focusing on moving patients away from addictive pain pills that often come with dangerous side effects and even overdose. “With pain pills, especially with nerve pain, it’s hard to target so it’s an ongoing issue. So, anyone using pain pills like opioids or narcotics, studies say that if you use it over a period of three months then technically you’re on it for good. You start to get a tolerance and it becomes very hard to get off of it. That’s why it’s become such an epidemic. There are huge amounts of overdosing. And we’re focusing more on that,” she says.  “Also, seniors are more at risk and have more tendencies to develop side effects such as ulcers and kidney malfunction with certain medications.”

Swan Lake pharmacy is hoping to change all that with compounding topical medicine to better target and manage their pain. “We’re focusing on cream medication to get patients off of pills. With compound cream, you’re getting all the medicinal ingredients you’d get in a pill but in cream form.”

Patients, according to Youssef, love the idea of treating their pain topically. She says although they began mainly treating senior citizens with compounding medicine, as they got more involved she found out that pretty much nobody wants to take pills. “People are heading towards not using pills if possible,” she reveals. “For example, a patient claiming, “my ankle hurts,” from injury, would rather have a cream than a pill to treat and directly target that area.”

swan lake pharmacy compounding medicine

Health Care First

When a patient visits Swan Lake Pharmacy, they do a quick assessment and, depending on a patient’s need, a compounded topical cream is formulated. “The ingredients in the cream depends on what the patient needs it for. We can put up to five or six ingredients in it, but it’s all custom,” Youssef explains. “The more topical the better. If topical works first, that’s the way to go. All doctors are on board with this, and we work closely with the patient’s family physician to approve what we’re recommending and they can approve or adjust levels of ingredients in the compound cream. Once the formula is created, and it is doctor approved, that’s when the patients can get off their medication.”

More than a Pharmacy

This type of targeted care is what’s making Swan Lake Pharmacy a leader in this field. But Youssef humbly attributes her success to her patients. “The patients here are very supportive. We just opened a year and a half ago and we have to thank our patients for being active and putting reviews online and coming back and giving us thanks.”

When it comes to setting her business apart from others, for Youssef it’s simple. “We don’t just look at prescriptions as counting pills. When a patient comes in with a full profile from their doctor we’ll actually recommend if they need to stop other medications that may interfere with their prescription. Then, they’ll go back to their physician and end up stopping another medication because it was affecting the quality of their life. For us, it’s about looking at the full picture for patients not just the pills their taking but how their lifestyle is going.”

Looking Ahead

Swan Lake Pharmacy hopes to expand in the near future to include more in-house products that you can currently buy through their e-commerce store swanlakepharmacy.com (where you can buy health and wellness products from vitamins to personal care items to over-the-counter medication) and by adding a dietician for therapeutic nutrition.

All around, she says that her mindset as a pharmacist is to also help change people’s lifestyle. “I just think people appreciate that we go that step further and consult with them instead of just going to any pharmacy and simply picking up their pills and getting some information about those pills and that’s it. Taking that one extra step for a patient will give you that patient’s loyalty for life.”

Youssef hopes to continue to lead the way in the compounding medicine industry and continue to research to help people not only manage pain but to also focus on preventative treatments and therapy.

 

 

 

 

 

 

Government announces more than $8 million to help strengthen and grow Canada’s organic sector

0
Government announces more than $8 million to help strengthen and grow Canada's organic sector

Minister of Agriculture and Agri-Food Lawrence MacAulay has announced a federal investment of up to $8.3 million to the Organic Federation of Canada, under the Canadian Agricultural Partnership, AgriScience Clusters.

This research investment, which includes an additional $4.4 million in contributions from industry, will help the organic sector enhance productivity through better soil health and fertility management, advance crop breeding research, improve pest management, and evaluate the environmental impacts of organic farm practices.

MacAulay also announced an additional investment of $292,555 to the Organic Federation of Canada under the federal Canadian Agricultural Adaptation program. The funding will assist industry in streamlining the review process of the Canadian Organic Standards and improve the Canadian organic industry’s competitiveness and international market access. This funding builds upon the $250,000 announced by the Minister on January 26, towards the Canadian General Standards Board to complete the 2020 review of the Canadian Organic Standards.

The announcement is part of MacAulay’s ‘Growing Canadian Agriculture’ tour, where he will meet with farmers, processors and industry leaders, as well as participate in rural agricultural events across the country, to hear ideas on how to capture new growth opportunities for the sector.

“Demand for our world-class Canadian organic products continues to grow around the world and our Government is proud to support our organic farmers and food processors so they can meet that demand,” MacAulay said.

“Today’s significant investment into the science of organic agriculture will help our organic farmers grow more and grow better. And, we are pleased to support the Canadian Organic Standards, which are the backbone of the organic industry.”

“The Organic Federation of Canada is very pleased with AAFC’s commitment to develop Canadian organic agriculture science and sustainability. This funding will allow researchers to continue improving the sustainability of agricultural practices, which is at the heart of organic production. The Canadian Organic Sustainability Framework supports the entire organic value-chain and review of the Canadian Organic Standards, which is essential for maintaining our integrity and competitiveness on the world stage. We value the Government of Canada as a partner of choice for the Canadian organic sector.”

4,000 jobs at risk as Sobeys closes, converts Safeway stores, union says

0
4

UFCW 1518is urging members to vote “No” and reject the recommendations issued by Special Officer Vince Ready in a province-wide vote next week.

In January, Sobeys closed 10 Safeway stores in British Columbia, suggesting it would reopen five of them if it got concessions in a new collective agreement. Negotiations between union and company stalled in March after Sobeys refused to budge from its concessions-only demands.

“If some of our members can’t even afford to shop at Safeway, I don’t know how Sobeys thinks they’d be able to live on less. Our members deserve a living wage, not poverty concessions,” said Union President Ivan Limpright.

“We have been at a deadlock from the beginning of negotiations. It was truly our hope with the appointment of the Special Officer that we would see some real movement to a resolution through mediation which is yet to happen,” Limpright added.

The union says Sobeys is attempting to gut the collective agreement and see workers endure more hardship. The recommendations also threaten the viability of the grocery industry in British Columbia, poised to start a race to the bottom in an already fierce market.

Limpright says the special officer’s recommendations would demand untold concessions from the majority of the union’s 4000 Safeway members through a process called Quarterly Review. Negotiations for the reopener of the collective agreement between UFCW 1518 and Sobeys would be placed on hold until an undetermined date, and the parties would begin bargaining for a new collective agreement for FreshCo, Sobeys discount banner. In other provinces, FreshCo also has a discount collective agreement, with inferior wages and benefits for workers.

“We’re holding a provincewide vote because we need to hear from members on this. The recommendations are so alarming that our bargaining committee is strongly urging our members reject them by voting no,” explained President Limpright. “We know our members will come out in force and tell Sobeys where to stick those recommendations.”

Loblaw to spin out its interest in Choice Properties REIT

0
Loblaw to spin out its interest in Choice Properties REIT

Loblaw Companies Ltd. and George Weston Ltd. (GWL) Have announced a reorganization under which Loblaw will spin out its 61.6 per cent interest in Choice Properties REIT.

Under the spin-out, Loblaw common shareholders other than GWL will receive 0.135 of a GWL common share per Loblaw share, which is equivalent to the market value of their pro rata interest in Choice Properties, and GWL will receive Loblaw’s 61.6 per cent interest in Choice Properties.

After the spin-out, Loblaw will not retain any equity interest in Choice Properties and will be a pure-play Canadian food and drug retailer.

“The reorganization will result in a more efficient group structure, that strategically benefits both Loblaw and Choice Properties, which in turn strengthens GWL,” said Galen G. Weston, Chairman and CEO, Loblaw Companies Ltd. and George Weston Ltd.

“Loblaw, Choice Properties and GWL investors will all benefit from the strategic and investment clarity this transaction brings.”

“Over the past few years, the strategies of Loblaw and Choice Properties have diverged. Loblaw is focused on strengthening its core retail business and growing in areas such as digital, healthcare, payments and rewards, while Choice Properties is focused on mixed-use development and investments in diversified real estate asset classes,” said Sarah Davis, President of Loblaw Companies Ltd.

“Our retail store network continues to be a key competitive advantage for us, but we don’t see ownershipof real estate as core to our strategy going forward.”

Loblaw plans to maintain its current quarterly common share dividend after the spin-out. GWL plans to raise its quarterly common share dividend by 5 per cent to $0.515 per share (or $2.06 per share annualized), contingent on the closing of this transaction.

Therefore, aggregating dividends from the two companies, Loblaw shareholders who hold their distributed GWL common shares post-closing of the transaction will receive a 24 per cent increase in their current dividend as a result of the spin-out.

The transaction will have no impact on the important, ongoing operating relationship between Loblaw and Choice Properties and all current agreements and arrangements, including the Strategic Alliance Agreement and leases, will remain in place after the spin-out. In addition, Loblaw will continue to be Choice Properties’ largest tenant.

Loblaw and GWL do not expect any change to the credit ratings of Loblaw, Choice Properties or GWL by Standard and Poor’s or DBRS as a result of the spin-out.

The plan of arrangement will require the approval of at least two-thirds of the votes cast by all the common shareholders of Loblaw, as well as a majority of the votes cast by Loblaw Minority Shareholders. The vote will be conducted at a special meeting of Loblaw shareholders expected to take place in October 2018.

La Coop fédérée Signs an Agreement with W-S Feed & Supplies Ltd

0
La Coop fédérée Signs an Agreement with W-S Feed & Supplies Ltd

La Coop fédérée, a Montreal-based agri-food co-operative with operations across Canada, and W-S Feed & Supplies Ltd., announced today that La Coop fédérée will purchase a 50% stake in the animal nutrition company based in Tavistock, Ont.

W-S Feeds operates two feed mills in Ontario, in Tavistock and Mount Forest. The new partnership will continue to manufacture a wide variety of feeds for dairy production, including organic, beef, swine and poultry production.

“This investment represents a strategic entry into the Ontario market, in the animal nutrition industry this time” says Ghislain Gervais, president of La Coop fédérée. “This partnership develops our portfolio of operations in the province and shows how important it is for us to provide farmers across the country with quality products and solutions for their animal feed,” he adds.

After recently gaining a foothold in the Prairie provinces for its animal feed activities with the acquisition of Standard Nutrition Canada, La Coop fédérée’s Agri-business Division keeps extending this line of business which is already well established in Quebec and the Maritimes. Earlier this year, the Agri-business Division also announced the acquisition of Cargill’s crop input and grain assets in Ontario, a transaction pending the approval of Canada’s Competition Bureau.

Young Living Sunscreen Receives Seal of Recommendation from The Skin Cancer Foundation

0
Young Living Sunscreen Receives Seal of Recommendation from The Skin Cancer Foundation

Young Living Essential Oils, the world leader in essential oils, announced today that its Mineral Sunscreen Lotion SPF 50 received the Seal of Recommendation from The Skin Cancer Foundation.

Lehi, Utah-baed Young Living’s Mineral Sunscreen meets the Foundation’s stringent criteria for safe and effective daily use broad spectrum (UVA and UVB) sun protection.

The Skin Cancer Foundation has set the standard for educating the public and the medical community about skin cancer, and focuses on decreasing the incidence and mortality of the world’s most common cancer. Occurring at epidemic levels, one in five Americans will develop skin cancer by the age of 70; and one person dies of melanoma, the most dangerous form of the disease, every hour.

To earn the Seal of Recommendation, a manufacturer must provide scientific data showing that its product adequately and safely “aids in the prevention of sun-induced damage to the skin.” The data is reviewed by a volunteer committee of photobiologists who are experts in the study of the interaction between ultraviolet radiation and the skin.

“When our scientists at Young Living formulated the Mineral Sunscreen, we wanted to offer people sun protection that doesn’t use harsh chemicals; and through our strict Seed to Seal process, we produced an effective, safe sunscreen that is genuine and pure for people of all ages,” said Dr. Michael Buch, Young Living Chief Science Officer. “We are proud that our Mineral Sunscreen will now carry The Skin Cancer Foundation’s Seal of Recommendation. (sflix.video) ”

Young Living’s Mineral Sunscreen Lotion SPF 50 is an over-the-counter, natural sunscreen that doesn’t contain chemical UV absorbers, making it a safe alternative for adults and kids.

Aurora Cannabis Closes $200-million Debt Facility with BMO

0
Aurora Cannabis Closes $200-million Debt Facility with BMO

Aurora Cannabis Inc. has closed a previously announced debt facility with the Bank of Montreal consisting of a $150-million term loan and a $50-million revolving credit facility, both of which mature in 2021.

Included in the facility is an option to upsize the facility to $250-million total following the implementation of Bill C-45 on October 17, 2018, subject to agreement by BMO and satisfaction of certain legal and business conditions.

The debt facility is primarily secured by Aurora’s production facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie.

Strategically located at Edmonton International Airport, Aurora Sky is the world’s most technologically advanced cannabis facility, projected to produce in excess of 100,000 kg per year of high-quality, low-cost per gram, cannabis upon completion.

“With BMO and the syndicate lenders, Aurora gains significant runway to expansion opportunities that will positively contribute to our long-term margin profile and provide accelerated entry into multiple international markets,” said Terry Booth, CEO of Aurora.

“This additional capital positions us well to continue building the pre-eminent global cannabis company with a focus on vertically integrated, geographically and horizontally diversified assets.”

Headquartered in Edmonton, Aurora is one of the world’s largest and leading cannabis companies.

Supreme Cannabis Approved for Additional Production Capacity

0
Supreme Cannabis Approved for Additional Production Capacity

TheSupreme Cannabis Company has obtained Health Canada approval to commence cultivation on approximately 20,000 square feet of additional flowering rooms at its 7ACRES facility.

The additional flowering rooms will increase total potential flowering capacity to 90,000 square feet and, assuming a current yield, will bring 7ACRES’ annual production potential from 10,000kg to 13,330kg.

“As the first coast-to-coast premium cannabis brand in Canada, 7ACRES is already one of the fastest scaling producers in the country. This flowering room expansion continues to increase our capacity and improve our ability to meet the demand of cannabis enthusiasts upon legalization of adult use cannabis in Canada,” said John Fowler, CEO of Supreme Cannabis.

Completion of flowering rooms at the 342,000-square foot 7ACRES facility remains on schedule for completion in December 2018. With an annual production capacity expected to reach 50,000 kg once the 7ACRES facility is fully operational, the Company is committed to supplying premium-quality cannabis flower to the Canadian recreational market from coast-to-coast.

Visit www.supreme.ca and www.7ACRES.com for more information.

The Canadian Medical Association to support communities of interests

0
The Canadian Medical Association to support communities of interests

The Canadian Medical Association (CMA) has announced the five recipients of the CMA Communities of Interest Grant Program. Launched earlier this year, the program aims to support an existing community of interest, or to develop a new one by providing funding, strategic support and community management coaching.

The CMA is developing a virtual platform, where communities can be hosted and supported online. The platform, to be launched later this year, will enable community members across Canada to easily connect, share resources and join discussions in a virtual space. It will also provide physicians, stakeholders and patients ways to connect with the CMA to provide feedback on policies and programs.

 

The 2018 recipients are:

  • Indigenous Health: This community of interest will examine indigenous health inequities and ways of resolving these inequities on a personal, organizational and institutional level, in conjunction with First Nations communities.
  • Creating an Inclusive and Equitable Medical Community: This community of interest will focus on building an inclusive medical culture – sharing stories, resources and opportunities – with the goal of achieving gender equity in medical communities.
  • IMAGINE (Interprofessional and Medical Allied Groups Improving Neighbourhood Environments) Health: This community of interest will build on IMAGINE’s work, providing basic healthcare to marginalized people in Toronto by increasing awareness of patient access issues and sharing information about the resources available across Canada for vulnerable populations.
  • Canadian Association of MAID Assessors and Providers: This community of interest will develop an existing mailing list – run by CAMAP – into a broad, national forum to share experiences, resources and expertise.
  • Substance Use: This community of interest aims to build a national network on substance use issues where resources, expertise and experiences can be shared, as well as develop policy recommendations to inform municipal, provincial and federal governments on substance use.

Each of these communities are supported by groups of physicians and medical learners who want to bring together stakeholders looking to address these issues.

Thirty-two scientists awarded grants from CAMH Discovery Fund

0
Thirty-two scientists awarded grants from CAMH Discovery Fund

An antidote for post-traumatic stress disorder. A nasal spray for panic attacks. An increase in brain plasticity, described by one successful applicant as the ‘Holy Grail’ of brain disorder research.

These are just a few of the first 32 exciting projects being funded by the Centre of Addiction and Mental Health’s (CAMH) Discovery Fund. It was created in January 2018 through a $100 million gift from an anonymous donor, the largest donation to mental health in Canadian history. Described at the time by CAMH’s CEO, Dr. Catherine Zahn as “an injection of wild, wild hope,” the Discovery Fund will attract and develop top talent, and nurture the kind of cutting-edge research and innovation that can lead to true breakthroughs in mental health treatment and care.

“This is only the beginning,” said Dr. Vicky Stergiopoulos, CAMH’s physician-in-chief. “There is such an urgent need for better understanding and treatments for people with mental illness. Through the Discovery Fund, we are focused on discovery and innovation to improve outcomes for those we serve today, as well as future generations, both here in Canada, and around the world.”

After each project was rigorously reviewed and evaluated by a team of internal and external experts, seven were granted two-year Seed Funding awards of up to $200,000.

Another 25 applications to the Talent Development fund, created to assist and inspire the next generation of mental health researchers, were also given the green light.

“We were tremendously impressed with the variety of truly innovative projects presented to us,” said Dr. Tarek Rajji, deputy physician-in-chief for Research at CAMH. “These are all important studies that could have a powerful impact on mental health in Canada and globally and we’re proud to be able to fund them through the Discovery Fund. Being able to fund high-risk/high-reward studies could lead to paradigm shifts in mental health research.”